Literature DB >> 9624128

Mapping of functional domains in p47(phox) involved in the activation of NADPH oxidase by "peptide walking".

I Morozov1, O Lotan, G Joseph, Y Gorzalczany, E Pick.   

Abstract

The superoxide generating NADPH oxidase of phagocytes consists, in resting cells, of a membrane-associated electron transporting flavocytochrome (cytochrome b559) and four cytosolic proteins as follows: p47(phox), p67(phox), p40(phox), and the small GTPase, Rac(1 or 2). Activation of the oxidase is consequent to the assembly of a membrane-localized multimolecular complex consisting of cytochrome b559 and the cytosolic components. We used "peptide walking" (Joseph, G., and Pick, E. (1995) J. Biol. Chem. 270, 29079-29082) for mapping domains in the amino acid sequence of p47(phox) participating in the molecular events leading to the activation of NADPH oxidase. Ninety-five overlapping pentadecapeptides, with a four-residue offset between neighboring peptides, spanning the complete p47(phox) sequence, were tested for the ability to inhibit NADPH oxidase activation in a cell-free system. This consisted of solubilized macrophage membranes, recombinant p47(phox), p67(phox), and Rac1, and lithium dodecyl sulfate, as the activator. Eight functional domains were identified and labeled a-h. These were (N- and C-terminal residue numbers are given for each domain) as follows: a (21-35); b (105-119); c (149-159); d (193-207); e (253-267); f (305-319); g (325-339), and h (373-387). Four of these domains (c, d, e, and g) correspond to or form parts of regions shown before to participate in NADPH oxidase assembly. Thus, domain c corresponds to a region on the N-terminal boundary of the first src homology 3 (SH3) domain, whereas domains d and e represent more precisely defined sites within the full-length first and second SH3 domains, respectively. Domain g overlaps an extensively investigated arginine-rich region. Domains a and b, in the N-terminal half of p47(phox), and domains f and h, in the C-terminal half, represent newly identified entities, for which there is no earlier experimental evidence of involvement in NADPH oxidase activation. "Peptide walking" was also applied to the identification of domains in p47(phox) mediating binding to p67(phox). This was done by quantifying, by enzyme-linked immunosorbent assay, the binding of p67(phox), in solution, to a series of 95 overlapping biotinylated p47(phox) peptides, attached to streptavidin-coated 96-well plates. A single proline-rich domain (residues 357-371) was found to bind p67(phox) in the absence and presence of lithium dodecyl sulfate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624128     DOI: 10.1074/jbc.273.25.15435

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Assembly of the phagocyte NADPH oxidase.

Authors:  William M Nauseef
Journal:  Histochem Cell Biol       Date:  2004-08-04       Impact factor: 4.304

2.  Hypothalamic proline-rich polypeptide is an oxidative burst regulator.

Authors:  Tigran K Davtyan; Hayk M Manukyan; Gagik S Hakopyan; Nana R Mkrtchyan; Samvel A Avetisyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

3.  Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation.

Authors:  Emily E Bosco; Sachin Kumar; Filippo Marchioni; Jacek Biesiada; Miroslaw Kordos; Kathleen Szczur; Jarek Meller; William Seibel; Ariel Mizrahi; Edgar Pick; Marie-Dominique Filippi; Yi Zheng
Journal:  Chem Biol       Date:  2012-02-24

4.  A prenylated p47phox-p67phox-Rac1 chimera is a Quintessential NADPH oxidase activator: membrane association and functional capacity.

Authors:  Ariel Mizrahi; Yevgeny Berdichevsky; Patrick J Casey; Edgar Pick
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 5.  Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors.

Authors:  M Eugenia Cifuentes-Pagano; Daniel N Meijles; Patrick J Pagano
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 6.  The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls.

Authors:  Eugenia Cifuentes-Pagano; Daniel N Meijles; Patrick J Pagano
Journal:  Antioxid Redox Signal       Date:  2013-12-14       Impact factor: 8.401

7.  A fluorescently tagged C-terminal fragment of p47phox detects NADPH oxidase dynamics during phagocytosis.

Authors:  Xing Jun Li; Wei Tian; Natalie D Stull; Sergio Grinstein; Simon Atkinson; Mary C Dinauer
Journal:  Mol Biol Cell       Date:  2009-01-07       Impact factor: 4.138

8.  Activation of the superoxide-producing phagocyte NADPH oxidase requires co-operation between the tandem SH3 domains of p47phox in recognition of a polyproline type II helix and an adjacent alpha-helix of p22phox.

Authors:  Ikuo Nobuhisa; Ryu Takeya; Kenji Ogura; Noriko Ueno; Daisuke Kohda; Fuyuhiko Inagaki; Hideki Sumimoto
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

Review 9.  Towards specific NADPH oxidase inhibition by small synthetic peptides.

Authors:  Jamel El-Benna; Pham My-Chan Dang; Axel Périanin
Journal:  Cell Mol Life Sci       Date:  2012-05-06       Impact factor: 9.261

Review 10.  Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".

Authors:  Iris Dahan; Edgar Pick
Journal:  Cell Mol Life Sci       Date:  2012-05-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.